Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan

Journal of Clinical Virology

Volumn 45, Issue 2, 2009, Pages 129-134

  Chi, Chia Yu ^a   Tseng, Fan Chen ^a   Liu, Ding Ping ^b   Chang, Ya Wen ^a   Wu, Han Chieh ^a   Huang, Yung Feng ^c   Hwang, Kao Pin ^d   Hsu, Yun Wei ^a   Wang, Shih Min ^e   Liu, Ching Chuan ^e   Wu, Ho Sheng ^b   Yang, Jyh Yuan ^b   Yang, Chen Fu ^b   Wang, Jen Ren ^a,f   Su, Ih Jen ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Myocarditis; OPV; Recombination; Revertants; Surveillance

Indexed keywords

ORAL POLIOMYELITIS VACCINE; TRIPLE VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GENETIC VARIABILITY; HUMAN; IMMUNIZATION; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TAIWAN; UPPER RESPIRATORY TRACT INFECTION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS STRAIN;

CHILD; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; PHYLOGENY; PNEUMONIA; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RESPIRATORY TRACT INFECTIONS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TAIWAN;

EID: 67349159709     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.03.013     Document Type: Article

References (43)

1. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., and Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 (2005) 587-635
2. Minor P.D. Polio eradication, cessation of vaccination and re-emergence of disease. Nat Rev Microbiol 2 (2004) 473-482
3. Alexander Jr. J.P., Gary Jr. H.E., and Pallansch M.A. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 175 (1997) S176-S182
4. Fine P.E., and Carneiro I.A. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 150 (1999) 1001-1021
5. Kew O.M., Wright P.F., Agol V.I., Delpeyroux F., Shimizu H., Nathanson N., et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82 (2004) 16-23
6. Mas Lago P., Caceres V.M., Galindo M.A., Gary Jr. H.E., Valcarcel M., Barrios J., et al. Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol 30 (2001) 1029-1034
7. Pallansch M., and Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields' virology. 5th ed. (2007), Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia 839-893
8. Minor P.D., and Almond J. Poliovirus vaccines: molecular biology and immune response. In: Semler B.L., and Wimmer E. (Eds). Molecular biology of picornaviruses (2002), ASM Press, Washington, D.C 381-390
9. CDC. Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001. MMWR Morb Mortal Wkly Rep 51 (2002) 369-371
10. CDC. Update on vaccine-derived polioviruses. MMWR Morb Mortal Wkly Rep 55 (2006) 1093-10937
11. Cuervo N.S., Guillot S., Romanenkova N., Combiescu M., Aubert-Combiescu A., Seghier M., et al. Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol 75 (2001) 5740-5751
12. Blomqvist S., Bruu A.L., Stenvik M., and Hovi T. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol 84 (2003) 573-580
13. Cherkasova E.A., Yakovenko M.L., Rezapkin G.V., Korotkova E.A., Ivanova O.E., Eremeeva T.P., et al. Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol 79 (2005) 1062-1070
14. Georgopoulou A., and Markoulatos P. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes. Eur J Clin Microbiol Infect Dis 20 (2001) 792-799
15. Paximadi E., Karakasiliotis I., Mamuris Z., Stathopoulos C., Krikelis V., and Markoulatos P. Genomic analysis of recombinant sabin clinical isolates. Virus Genes 32 (2006) 203-210
16. Shimizu H., Thorley B., Paladin F.J., Brussen K.A., Stambos V., Yuen L., et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78 (2004) 13512-13521
17. Arita M., Zhu S.L., Yoshida H., Yoneyama T., Miyamura T., and Shimizu H. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 79 (2005) 12650-12657
18. Rousset D., Rakoto-Andrianarivelo M., Razafindratsimandresy R., Randriamanalina B., Guillot S., Balanant J., et al. Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9 (2003) 885-887
19. Yang C.F., Naguib T., Yang S.J., Nasr E., Jorba J., Ahmed N., et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77 (2003) 8366-8377
20. Shih S.R., Chen G.W., Yang C.C., Yang W.Z., Liu D.P., Lin J.H., et al. Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol 43 (2005) 1651-1661
21. Tseng F.C., Huang H.C., Chi C.Y., Lin T.L., Liu C.C., Jian J.W., et al. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J Med Virol 79 (2007) 1850-1860
22. World Health Organization. Dept. of Immunization Vaccines and Biologicals. Polio laboratory manual. 4th ed. Geneva: Immunization, Vaccines and Biologicals, World Health Organization; 2004.
23. Faden H., Modlin J.F., Thoms M.L., McBean A.M., Ferdon M.B., and Ogra P.L. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 162 (1990) 1291-1297
24. Laassri M., Dragunsky E., Enterline J., Eremeeva T., Ivanova O., Lottenbach K., et al. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol 43 (2005) 2886-2894
25. Modlin J.F., Halsey N.A., Thoms M.L., Meschievitz C.K., Patriarca P.A., and Baltimore Area Polio Vaccine Study Group. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis 175 (1997) S228-S234
26. Ramsay M.E., Begg N.T., Gandhi J., and Brown D. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines. Pediatr Infect Dis J 13 (1994) 1117-1121
27. Samoilovich E., Roivainen M., Titov L.P., and Hovi T. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children. J Med Virol 71 (2003) 274-280
28. Swartz T.A., Green M.S., Handscher R., Sofer D., Cohen-Dar M., Shohat T., et al. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel. Vaccine 26 (2008) 1083-1090
29. Yang C.F., Chen H.Y., Jorba J., Sun H.C., Yang S.J., Lee H.C., et al. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 79 (2005) 12623-12634
30. Wattigney W.A., Mootrey G.T., Braun M.M., and Chen R.T. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Pediatrics 107 (2001) E83
31. Abbink F., Buisman A.M., Doornbos G., Woldman J., Kimman T.G., and Conyn-van Spaendonck M.A. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. J Infect Dis 191 (2005) 990-999
32. Conyn-Van Spaendonck M.A., de Melker H.E., Abbink F., Elzinga-Gholizadea N., Kimman T.G., and van Loon T. Immunity to poliomyelitis in The Netherlands. Am J Epidemiol 153 (2001) 207-214
33. Macadam A.J., Arnold C., Howlett J., John A., Marsden S., Taffs F., et al. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172 (1989) 408-414
34. Macadam A.J., Pollard S.R., Ferguson G., Skuce R., Wood D., Almond J.W., et al. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192 (1993) 18-26
35. Rezapkin G.V., Fan L., Asher D.M., Fibi M.R., Dragunsky E.M., and Chumakov K.M. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Virology 258 (1999) 152-160
36. Baboonian C., Davies M.J., Booth J.C., and McKenna W.J. Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 223 (1997) 31-52
37. Kim K.S., Hufnagel G., Chapman N.M., and Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 11 (2001) 355-368
38. Woodruff J.F. Viral myocarditis: a review. Am J Pathol 101 (1980) 425-484
39. Jungeblut C.W., and Edwards J.E. Isolation of poliomyelitis virus from the heart in fatal cases. Am J Clin Pathol 21 (1951) 601-623
40. Saphir O., and Field M. Complications of myocarditis in children. J Pediatr 45 (1954) 457-463
41. Weinstein L., and Shelokov A. Cardiovascular manifestations in acute poliomyelitis. N Engl J Med 244 (1951) 281-285
42. Shulman L.M., Handsher R., Yang C.F., Yang S.J., Manor J., Vonsover A., et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol 38 (2000) 945-952
43. Guillot S., Caro V., Cuervo N., Korotkova E., Combiescu M., Persu A., et al. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74 (2000) 8434-8443